Saint Louis Cancer and Breast Institute-South City — St Louis, Missouri

Saint Louis Cancer and Breast Institute-South City is a clinical research site located in St Louis, Missouri, United States 63109.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Saint Louis Cancer and Breast Institute-South City has participated in 163 clinical trials with 60 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Louis Cancer and Breast Institute-South City?

Saint Louis Cancer and Breast Institute-South City has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Louis Cancer and Breast Institute-South City conducted?

Saint Louis Cancer and Breast Institute-South City has 163 clinical trials on record, with 60 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is Saint Louis Cancer and Breast Institute-South City accredited by Crixeo Health?

Saint Louis Cancer and Breast Institute-South City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Louis Cancer and Breast Institute-South City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.